References
Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20:168–172.
Cattan D, Roucayrol A-M, Launay J-M, Callebert J, et al. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology. 1989;97:586–596.
Wardlaw R, Smith JW. Gastric carcinoid tumors. Ochsner J. 2008;8:191–196.
Kulke MH. Neuroendocrine tumors: clinical presentation and management of localized disease. Cancer Treat Rev.. 2003;29:363–370.
Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterol. 2005;128:1717–1751.
Delle Fave G, Capurso G, Milione M, et al. Endocrine tumors of the stomach. Best Pract Res Clin Gastroenterol. 2005;19:659–673.
Jianu CS, Fossmark R, Viset T, Qvigstad G, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther. 2012;36:644–649.
Cavalcoli F, Zilli A, Conte D, et al. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? Scand J Gastroenterol. 2015; 1–7. (Epub ahead of print).
Lahner E, Pilozzi E, Esposito G, Galli G, et al. Gastric Carcinoid in the absence of atrophic body gastritis with low Ki67 index: a clinical challenge. Scand J Gastro. 2014;49:506–510.
Goo T, Akiba Y, Kaunitz JD. Mechanisms of intragastric pH sensing. Curr Gastroenterol Rep. 2010;12:465–470.
Feng J, Petersen CD, Coy DH, Thomas CJ, et al. Calcium-sensing receptor is a physiological multimodal chemosensor regulating gastric G-cell growth and gastrin secretion. Proc Natl Acad Sci USA. 2010;107:17791–17796.
Graham DY, Genta RM. Long term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep.. 2008;10:543–547.
Waldum HL, Gustaffson B, Fossmark R, et al. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50:S39–S44.
McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol. 2010;26:624–634.
Jianu CS, Lange OJ, Viset T, Qvigstad G, et al. Gastric neuroendocrine carcinoma after long-term use of a proton pump inhibitor. Scand J Gastroenterol. 2012;47:64–67.
Haga Y, Nakatsura T, Shibata Y, et al. Human gastric carcinoid detected during long-term anti-ulcer therapy of H2-receptor antagonist and proton pump inhibitor. Dig Dis Sci. 1998;43:253–257.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial disclosures or conflicts of interests.
Rights and permissions
About this article
Cite this article
Nandy, N., Hanson, J.A., Strickland, R.G. et al. Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature. Dig Dis Sci 61, 708–712 (2016). https://doi.org/10.1007/s10620-015-4014-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-4014-0